Multiple Sclerosis (MS)
An estimated 350,000 people in the United States are living with multiple sclerosis (MS), a debilitating and sometimes fatal disorder of the central nervous system.
Numerous case studies, surveys and double-blind studies have reported improvement in patients treated with cannabinoids for symptoms including spasticity, chronic pain, tremor, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance (ataxia), and memory loss. Medical marijuana has been shown in animal models to measurably lessen MS symptoms and may also halt the progression of the disease.
In addition to studying the potential role of medical marijuana and its derivatives in the treatment of MS-related symptoms, scientists are exploring the potential of medical marijuana to inhibit neurodegeneration.